LCS
THC icon

Levin Capital Strategies’s Tenet Healthcare THC Stock Holding History

Levin Capital Strategies’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,286
Closed -$1.5M – 272
2024
Q1 		$1.5M Sell
14,286
-8,000
-36% -$719K 0.15% 79
2023
Q4 		$1.68M Buy
+22,286
New +$1.41M 0.18% 76
2016
Q4 		– Sell
-26,500
Closed -$600K – 334
2016
Q3 		$600K Sell
26,500
-5,270
-17% -$137K 0.01% 213
2016
Q2 		$878K Buy
31,770
+15,770
+99% +$466K 0.02% 176
2016
Q1 		$463K Buy
+16,000
New +$416K 0.01% 233
2015
Q4 		– Sell
-39,000
Closed -$1.44M – 375
2015
Q3 		$1.44M Buy
39,000
+29,000
+290% +$1.5M 0.02% 175
2015
Q2 		$579K Sell
10,000
-8,000
-44% -$409K 0.01% 251
2015
Q1 		$891K Buy
18,000
+13,000
+260% +$608K 0.01% 229
2014
Q4 		$253K Buy
5,000
+1,000
+25% +$52.3K ﹤0.01% 345
2014
Q3 		$238K Sell
4,000
-3,500
-47% -$195K ﹤0.01% 318
2014
Q2 		$352K Sell
7,500
-2,500
-25% -$113K 0.01% 297
2014
Q1 		$428K Buy
+10,000
New +$441K 0.01% 266

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Levin Capital Strategies's THC Position: Q2 2024 in Review

Levin Capital Strategies sold out of Tenet Healthcare (THC) in Q2 2024, closing a stake of 14,286 shares — an estimated $1.5M sold.

Levin Capital Strategies first reported a position in THC in Q1 2014 and held it in 12 quarters. The position peaked at $1.68M in Q4 2023. 528 funds tracked by Wall St. Rank hold THC as of Q2 2024.

  • Levin Capital Strategies reported no remaining Tenet Healthcare position as of Q2 2024 after selling out during the quarter.
  • Levin Capital Strategies sold 14,286 Tenet Healthcare shares in Q2 2024, an estimated $1.5M.
  • Levin Capital Strategies first reported a position in Tenet Healthcare in Q1 2014 and held it in 12 quarters.
  • Levin Capital Strategies's Tenet Healthcare position peaked at $1.68M in Q4 2023.
  • 528 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2024.

Based on Levin Capital Strategies's 13F filing for Q2 2024, filed 7 Aug 2024.